Paul M. Titchenell - Concepedia

Author

Paul M. Titchenell

Also Known As

Cheng, Kenneth King Yip, Kaestner, Klaus H, Kenneth King Yip Cheng, P.M. Titchenell, PAUL M. TITCHENELL, Paul M Titchenell, Paul M. Titchenell, Paul Titchenell, Paul M. Titchenell

Publications

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Princeton University Harvard University Cardiovascular Institute of the South Pennsylvania State University

About

Paul M. Titchenell is an author at University of Pennsylvania specializing in medicine, biochemistry, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	2.1K
2	Biochemistry	8	8	964
3	Health Sciences	6	6	1.2K
4	Cell Biology	5	5	502
5	Natural Sciences	2	2	113

Paul M. Titchenell

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes Rachel J. Perry, João Paulo Camporez, Romy Kursawe, Cell ObesityMetabolic SyndromeInsulin SignalingHepatologyMetabolic Associated Steatotic Liver Disease	2015	693
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate Steven Zhao, Cholsoon Jang, Joyce Liu, Nature BiochemistryLipid NutritionLiver PhysiologyMicrobiota-derived AcetateMicrobiology	2020	528
Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production Paul M. Titchenell, William J. Quinn, Mingjian Lu, Cell Metabolism Metabolic SyndromeInsulin SignalingIs DispensableHepatologyLiver Physiology	2016	269
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo Paul M. Titchenell, Qingwei Chu, Bobby R. Monks, Nature Communications	2015	165
The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis Natasha Jaiswal, M.G. Gavin, William J. Quinn, Molecular Metabolism	2019	165
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver Kashyap Patel, Marc Foretz, Allison Marion, Nature Communications	2014	161
Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1 Bridget S. Gosis, Shogo Wada, Chelsea Thorsheim, Science ImmunologyPathologyPharmacotherapyRapamycin Complex 1Fatty Liver Disease	2022	150
mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion William J. Quinn, Min Wan, Swapnil V. Shewale, Journal of Clinical Investigation Lipid MovementMetabolic SyndromeFatty AcidsNutrient SignallingPhosphatidylcholine Synthesis	2017	98
SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding Hagoon Jang, Gha Young Lee, Christopher P. Selby, Nature Communications	2016	97
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism Elizabeth de Fougerolles Nunn, Natasha Jaiswal, Matthew Gavin, Molecular Metabolism	2024	84

Page 1